Prot #GA29102: Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy (Maintenance Of Remission) And Safety Of Etrolizumab Compared With Placebo In Patients With Moderate To Severe Active Ulcerative Colitis Who

Project: Research project

Project Details

StatusFinished
Effective start/end date3/17/153/17/21

Funding

  • Quintiles, Inc. (Prot #GA29102 // Prot #GA29102)
  • Genentech, Inc (Prot #GA29102 // Prot #GA29102)